posted on 2025-08-02, 10:51authored byH Minnee, JGM Rack, GA van der Marel, HS Overkleeft, JDC Codée, I Ahel, D Filippov
The transfer of an adenosine diphosphate (ADP) ribose moiety to a nucleophilic side chain by consumption of nicotinamide adenine dinucleotide is referred to as ADP-ribosylation, which allows for the spatiotemporal regulation of vital processes such as apoptosis and DNA repair. Recent mass-spectrometry based analyses of the ‘ADP-ribosylome’ have identified histidine as ADP-ribose acceptor site. In order to study this modification, a fully synthetic strategy towards α-configured N(τ)- and N(π)-ADP-ribosylated histidine-containing peptides has been developed. Ribofuranosylated histidine building blocks were obtained via Mukaiyama-type glycosylation and the building blocks were integrated into an ADP-ribosylome derived peptide sequence using fluorenylmethyloxycarbonyl (Fmoc)-based solid-phase peptide synthesis. On-resin installation of the ADP moiety was achieved using phosphoramidite chemistry, and global deprotection provided the desired ADP-ribosylated oligopeptides. The stability under various chemical conditions and resistance against (ADP-ribosyl) hydrolase-mediated degradation has been investigated to reveal that the constructs are stable under various chemical conditions and non-degradable by any of the known ADP-ribosylhydrolases.
Funding
210634
223107
813369
BB/R007195/1
BB/W016613/1
Biotechnology and Biological Sciences Research Council (BBSRC)
C35050/A22284
Cancer Research UK
MR/N006364/2
MR/V033417/1
MR/X007472/1
Medical Research Council (MRC)
National Institute for Health and Care Research (NIHR)